Case-costing of palliative radiotherapy: A Canadian single-institution perspective

Current Oncology

Volumn 9, Issue 1, 2002, Pages 20-26

  Samant, Rajiv S ^a   Roberts, G H ^a   Dunscombe, P B ^a  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; HYDROMORPHONE; MORPHINE; RECOMBINANT ERYTHROPOIETIN; RITUXIMAB; TRASTUZUMAB;

ANEMIA; ARTICLE; CANADA; CANCER; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CATARACT; COBALT TELETHERAPY; DIALYSIS; HEALTH CARE COST; HUMAN; INGUINAL HERNIA; KIDNEY DISEASE; OUTCOMES RESEARCH; PAIN; RADIATION DOSE FRACTIONATION; TOTAL HIP PROSTHESIS;

EID: 0036300027     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. The palliative role of radiotherapy in the management of the cancer patient
2. Cost aspects of palliative cancer care
3. An overview of cancer economics. Based on a presentation by C. Daniel Mullins, PhD
4. Measuring the cost of palliative radiotherapy
5. Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective
6. Economic issues in lung cancer: A review
7. Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer
8. Assessing the cost-effectiveness of postmastectomy radiation therapy
9. Efficacy and cost-effectiveness of cancer treatment: Rational allocation of resources based on decision analysis
10. The role of radiotherapy in Sweden-a landmark study by the Swedish Council on Technology Assessment in Health Care
11. Does a centralized radiotherapy system provide adequate access to care?
12. Quality of life after palliative radiotherapy in non-small cell lung cancer: A prospective study
13. Pain relief and quality of life following radiotherapy for bone metastases: A randomised trial of two fractionation schedules
14. Radiation therapy in the management of distant breast cancer metastases
15. The effect of a single fraction compared to multiple fractions on painful bone metastases: A global analysis of the Dutch Bone Metastasis Study
16. New study suggests radiation often underused for palliation
17. Audit in radiation therapy: Long-term survival and cost of treatment
18. Palliative radiation therapy in the United States
19. Association between age and the utilization of radiotherapy in Ontario
20. Cost accounting in radiation oncology: A computer-based model for reimbursement
21. Cost of radiotherapy in Sweden
22. The cost of radiation treatment at an Ontario regional cancer centre
23. The cost-effectiveness and cost-utility of high-dose palliative radiotherapy for advanced non-small-cell lung cancer
24. The economic evaluation of cancer treatments and programmes
25. Palliative radiotherapy for skeletal metastases: Cost-substitution analyses and economic impact
26. The economic characterization of radiation treatment processes within a cancer care program
27. A cost-outcome analysis of adjuvant postmastectomy locoregional radiotherapy in premenopausal node-positive breast cancer patients
28. Radiotherapy services in Canada: Equipment and staff workloads
29. Evaluating the impact of radiotherapy on the quality of life of cancer patients by two simple indexes. A pilot study
30. Quality of life after palliative radiotherapy in patients with hormone-resistant prostate cancer: Single institution experience
31. Quality-of-life assessment during palliative radiotherapy
32. Measuring the benefit and toxicity of palliative radiotherapy
33. Palliative effectiveness of radiation therapy in the treatment of superior vena cava syndrome
34. The EORTC core quality of life questionnaire (QLQ-C30): Validity and reliability when analysed with patients treated with palliative radiotherapy
35. A retrospective quality of life analysis using the Lung Cancer Symptom Scale in patients treated with palliative radiotherapy for advanced non-small-cell lung cancer
36. Inoperable non-small-cell lung cancer (NSCLC): A Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party
37. Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: Based on a Canadian randomized trial with palliative end points
38. The cost of radiotherapy at an Ontario regional cancer centre: A reevaluation
39. Brief courses of palliative radiotherapy for metastatic bone pain: A pilot cost-minimization comparison with narcotic analgesics
40. Treatment of local recurrences of rectal carcinoma
41. Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer
42. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations
43. Five-hundred life-saving interventions and their cost-effectiveness
44. Palliative management of brain metastases
45. Prognosis of patients treated for intracranial metastases with whole-brain irradiation